Starving cancer: cholesterol drugs tested to slow deadly pancreatic tumors
NCT ID NCT04862260
Summary
This early-stage study is testing whether adding three common cholesterol-lowering drugs to standard chemotherapy is safe and feasible for people with advanced pancreatic cancer. The idea is that by drastically lowering the body's cholesterol, the drugs might 'starve' the fast-growing cancer cells and make chemotherapy more effective. The study will enroll a small number of newly diagnosed patients to check safety and gather initial data on how tumors respond.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHU de Québec-Université Laval
Québec, Quebec, G1R 2J6, Canada
-
CHUM
Montreal, Quebec, H2X 0A9, Canada
Conditions
Explore the condition pages connected to this study.